Spots Global Cancer Trial Database for Examination of the Pancreas in New-onset Diabetes

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Examination of the Pancreas in New-onset Diabetes

Official Title: Examination of the Pancreas in New-onset Diabetes (EXPAND Study)

Study ID: NCT02001337

Conditions

Diabetes Mellitus

Interventions

medical chart review

survey administration

Specimen collection

Study Description

Brief Summary: The purpose of this study is to create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and then screen this cohort for pancreatic cancer

Detailed Description: Compared to the general population, subjects \>50 years of age with new-onset diabetes (DM) are 8-times more likely to have pancreatic cancer (PaC). The likelihood of PaC in new-onset DM is further increased in those who have weight loss or elevated CA19-9. In this study patients with newly diagnosed diabetes will be prospectively identified. Those with weight loss and/or elevated pancreatic cancer marker (CA 19-9) will undergo pancreatic imaging. All subjects will be followed up to 24 months. If successful in identifying surgically removable PaC, this study will fundamentally change our practice and will be a major breakthrough in PaC treatment and research.